ROHAN PALEKAR - 02 Mar 2022 Form 3 Insider Report for Neoleukin Therapeutics, Inc. (NLTX)

Role: Director
Signature: /s/ Sean Smith, as Attorney-in-Fact for Rohan Palekar
Issuer symbol: NLTX
Transactions as of: 02 Mar 2022
Transactions value $: $0
Form type: 3
Filing time: 04 Mar 2022, 16:28:48 UTC
Previous filing: 22 Feb 2022
Next filing: 16 May 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24 - Power of Attorney